FdaApplication
ANDA 204025
Identifiers
- fda_app_no: ANDA204025
Properties
| Property | Value |
|---|---|
| applicant_name | ACCORD HEALTHCARE INC |
| application_type | ANDA |
| approval_date | 2020-08-26 |
Products (1)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| FOSAPREPITANT DIMEGLUMINE | FOSAPREPITANT DIMEGLUMINE | EQ 150MG BASE/VIAL | POWDER;INTRAVENOUS |
1 product